Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 5,414.15
-9.45 (-0.17%)
At close: Sep 25, 2026
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 89.87 billion as of September 25, 2026. Its market cap has decreased by -13.95% in one year.
Market Cap
89.87B
Enterprise Value
88.11B
Revenue
14.33B
Ranking
n/a
PE Ratio
28.50
Stock Price
5,414.15
ChartMarket Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 89.87B, an increase of 822.16%. That is a compound annual growth rate of 8.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 89.87B | -5.03% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 170.13B |
| AstraZeneca Pharma India | 162.95B |
| Viyash Scientific | 106.69B |
| Bliss GVS Pharma | 75.38B |
| Sanofi India | 72.31B |
| Morepen Laboratories | 66.00B |
| FDC Limited | 55.53B |
| Novartis India | 48.43B |